Please provide your email address to receive an email when new articles are posted on . In patients with moderate to severe eosinophilic asthma, treatment with dexpramipexole depleted blood and tissue ...
Hypereosinophilic syndrome (HES) is a heterogeneous disorder characterised by persistent, abnormal eosinophil elevation in ...
Please provide your email address to receive an email when new articles are posted on . Patients with advanced COPD and blood eosinophils of 100 or less had more exacerbations and reduced lung ...
Dupilumab (interleukin-4Rα; antibody binds to interleukin-4Rα, inhibiting interleukin-4 and interleukin-13 signaling in hematopoietic cells [e.g., B cells, CD4+ helper T cells, and eosinophils], ...
PITTSBURGH--(BUSINESS WIRE)--Knopp Biosciences LLC today reported further clinical and biomarker data demonstrating that reduction in eosinophil count by oral dexpramipexole significantly correlated ...
Eosinophils are a type of white blood cell. Low eosinophil numbers may occur due to certain medications or an underlying health condition, such as Cushing syndrome. Eosinophils play a role in the ...
A retrospective case series found that treatment with an interleukin (IL)-5 inhibitor reduced eosinophil levels and improved clinical outcomes in patients with drug reaction with eosinophilia and ...
Monoclonal antibodies targeting IgE, interleukin-4 and -13, and interleukin-5 are effective in treating severe type 2 asthma, but new targets are needed. Itepekimab is a new monoclonal antibody ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback